<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font32">VGCV </span>
   <span class="font30">Ad-infected </span>
   <span class="font28">hamsters </span>
   <span class="font27">virus </span>
   <span class="font24">(Figure </span>
   <span class="font24">animals </span>
   <span class="font23">adenovirus </span>
   <span class="font23">weight </span>
   <span class="font22">treatment </span>
   <span class="font21">challenge </span>
   <span class="font21">pathology </span>
   <span class="font20">burden </span>
   <span class="font20">days </span>
   <span class="font20">infection </span>
   <span class="font20">{border-style </span>
   <span class="font19">group </span>
   <span class="font19">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">Ad-Vehicle </span>
   <span class="font18">[]. </span>
   <span class="font18">lungs </span>
   <span class="font18">Syrian </span>
   <span class="font18">post </span>
   <span class="font17">dose </span>
   <span class="font17">immunosuppressed </span>
   <span class="font17">replication </span>
   <span class="font17">human </span>
   <span class="font17">used </span>
   <span class="font16">body </span>
   <span class="font16">drug </span>
   <span class="font16">hamsters. </span>
   <span class="font16">CDV </span>
   <span class="font16">hamster </span>
   <span class="font16">i.v. </span>
   <span class="font15">Hamsters </span>
   <span class="font15">challenge, </span>
   <span class="font15">patients </span>
   <span class="font15">B). </span>
   <span class="font15">VGCV-treated </span>
   <span class="font15">animal </span>
   <span class="font15">efficacy </span>
   <span class="font15">error </span>
   <span class="font15">immunocompromised </span>
   <span class="font15">liver </span>
   <span class="font15">species </span>
   <span class="font15">study </span>
   <span class="font14">(for </span>
   <span class="font14">HAdV-C </span>
   <span class="font14">groups </span>
   <span class="font14">hamsters, </span>
   <span class="font14">mean. </span>
   <span class="font14">model </span>
   <span class="font14">mortality </span>
   <span class="font14">treat </span>
   <span class="font14">vehicle-treated </span>
   <span class="font14">Ad, </span>
   <span class="font14">Figure </span>
   <span class="font14">deaths </span>
   <span class="font14">effective </span>
   <span class="font14">levels </span>
   <span class="font14">px; </span>
   <span class="font14">represents </span>
   <span class="font14">respiratory </span>
   <span class="font14">severe </span>
   <span class="font14">significant </span>
   <span class="font14">symbol </span>
   <span class="font14">{font-family </span>
   <span class="font13">Ad-VGCV </span>
   <span class="font13">Ad. </span>
   <span class="font13">Ads </span>
   <span class="font13">active </span>
   <span class="font13">collected </span>
   <span class="font13">decreased </span>
   <span class="font13">differences </span>
   <span class="font13">disseminated </span>
   <span class="font13">font-size </span>
   <span class="font13">i.n. </span>
   <span class="font13">infections </span>
   <span class="font13">loss </span>
   <span class="font13">lower </span>
   <span class="font13">lungs, </span>
   <span class="font13">mg/kg </span>
   <span class="font13">morbidity </span>
   <span class="font13">noted </span>
   <span class="font13">pathogenicity </span>
   <span class="font13">pathology. </span>
   <span class="font13">permissive </span>
   <span class="font13">results </span>
   <span class="font13">sacrificed </span>
   <span class="font13">study. </span>
   <span class="font13">syrian </span>
   <span class="font13">(A) </span>
   <span class="font13">(B) </span>
   <span class="font13">Ad- </span>
   <span class="font13">Ad-induced </span>
   <span class="font13">administered </span>
   <span class="font13">cause </span>
   <span class="font13">caused </span>
   <span class="font13">cell </span>
   <span class="font13">changes. </span>
   <span class="font13">data </span>
   <span class="font13">double; </span>
   <span class="font13">drugs </span>
   <span class="font13">high </span>
   <span class="font13">infections. </span>
   <span class="font13">kidney </span>
   <span class="font13">liver, </span>
   <span class="font13">lung </span>
   <span class="font13">mitigated </span>
   <span class="font13">observed </span>
   <span class="font13">organs </span>
   <span class="font13">purchased </span>
   <span class="font13">reduced </span>
   <span class="font13">serum </span>
   <span class="font13">showed </span>
   <span class="font13">shown </span>
   <span class="font13">transaminase </span>
   <span class="font13">treated </span>
   <span class="font13">using </span>
   <span class="font13">value </span>
   <span class="font12">-fold </span>
   <span class="font12">A). </span>
   <span class="font12">Ad-challenged </span>
   <span class="font12">Body </span>
   <span class="font12">CDV, </span>
   <span class="font12">However, </span>
   <span class="font12">Immunosuppressed </span>
   <span class="font12">Infection </span>
   <span class="font12">Marrow </span>
   <span class="font12">PFU/kg </span>
   <span class="font12">VGCV, </span>
   <span class="font12">Virus </span>
   <span class="font12">analyzed </span>
   <span class="font12">animal; </span>
   <span class="font12">anti-adenoviral </span>
   <span class="font12">bar </span>
   <span class="font12">bars </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">challenge) </span>
   <span class="font12">day </span>
   <span class="font12">described </span>
   <span class="font12">effect </span>
   <span class="font12">efficacious </span>
   <span class="font12">female </span>
   <span class="font12">horizontal </span>
   <span class="font12">however, </span>
   <span class="font12">individual </span>
   <span class="font12">infection, </span>
   <span class="font12">known </span>
   <span class="font12">losing </span>
   <span class="font12">lost </span>
   <span class="font12">lungs. </span>
   <span class="font12">male </span>
   <span class="font12">model. </span>
   <span class="font12">mottled </span>
   <span class="font12">necropsy </span>
   <span class="font12">prevented </span>
   <span class="font12">significantly </span>
   <span class="font12">signifies </span>
   <span class="font12">solid; </span>
   <span class="font12">standard </span>
   <span class="font12">starting </span>
   <span class="font12">test </span>
   <span class="font12">time </span>
   <span class="font12">transplant </span>
   <span class="font12">treatment-related </span>
   <span class="font12">untreated </span>
   <span class="font12">use </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">Ad-CDV </span>
   <span class="font12">GCV </span>
   <span class="font12">Treatment </span>
   <span class="font12">acute </span>
   <span class="font12">antiviral </span>
   <span class="font12">approved </span>
   <span class="font12">bold </span>
   <span class="font12">brincidofovir </span>
   <span class="font12">challenge. </span>
   <span class="font12">compared </span>
   <span class="font12">completely </span>
   <span class="font12">courier; </span>
   <span class="font12">demonstrated </span>
   <span class="font12">em; </span>
   <span class="font12">extent </span>
   <span class="font12">findings </span>
   <span class="font12">group. </span>
   <span class="font12">hematopoietic </span>
   <span class="font12">immunocompetent </span>
   <span class="font12">infected </span>
   <span class="font12">inhibits </span>
   <span class="font12">input </span>
   <span class="font12">lesions </span>
   <span class="font12">lesser </span>
   <span class="font12">mean; </span>
   <span class="font12">oncolytic </span>
   <span class="font12">prevents </span>
   <span class="font12">prophylactic </span>
   <span class="font12">pt;} </span>
   <span class="font12">result </span>
   <span class="font12">study, </span>
  </p>
 </body>
</html>
